Communiqués AVITA Medical, Inc.

Actions

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 15/07/2024			Varia. 5j.	Varia. 1 janv.
9,86 ^USD	+5,34 %		+18,94 %	-28,13 %

01/07	AVITA Medical, Inc. annonce des changements au sein de sa direction	CI
06/06	Le dispositif de prélèvement de cellules d'Avita Medical traite le premier patient américain ; les actions augmentent de 5%.	MT

AVITA Medical to Announce Second Quarter 2024 Financial Results	11/07	AQ
AVITA Medical Appoints Nicole Kelsey as Chief Legal and Compliance Officer, and Corporate Secretary	01/07	AQ
AVITA Medical Achieves Milestone with First Case Using RECELL GO	05/06	AQ
AVITA Medical Announces FDA Approval of RECELL GO	30/05	AQ
AVITA Medical to Host Investor Webinar Briefing	17/05	AQ
AVITA Medical Reports First Quarter Financial Results	13/05	AQ
AVITA Medical to Announce First Quarter 2024 Financial Results	15/04	AQ
AVITA Medical Updates Expected First Quarter 2024 Revenue	10/04	AQ
AVITA Medical Submits Response to FDA, Resuming Review Clock for RECELL GO PMA Supplement	29/02	AQ
AVITA Medical to Present at TD Cowen 44th Annual Health Care Conference	29/02	AQ
Morgans rates AVH as Add	26/02	AQ
AVITA Medical to Host Investor Webinar Briefing	23/02	AQ
AVITA Medical Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance	22/02	AQ
AVITA Medical to Announce Fourth Quarter and Full Year 2023 Financial Results	01/02	AQ
AVITA Medical Announces Exclusive Distribution Agreement with Stedical Scientific	10/01	AQ
AVITA Medical Announces Preliminary 2023 Financial Highlights, Provides 2024 Financial Guidance and Business Update	10/01	AQ
AVITA Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference	04/01	AQ
AVITA Medical to Host Investor Webinar Briefing	04/12	AQ
AVITA Medical to Present at the Piper Sandler 35th Annual Healthcare Conference	21/11	AQ
AVITA Medical Updates Full Year 2023 Guidance	20/11	AQ

Aucun résultat pour cette recherche